These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 10494043)
1. A nontoxic Pseudomonas exotoxin A induces active immunity and passive protective antibody against Pseudomonas exotoxin A intoxication. Chen TY; Lin CP; Loa CC; Chen TL; Shang HF; Hwang J; Hui CF J Biomed Sci; 1999; 6(5):357-63. PubMed ID: 10494043 [TBL] [Abstract][Full Text] [Related]
2. Characterization of monoclonal antibody B7, which neutralizes the cytotoxicity of Pseudomonas aeruginosa exotoxin A. Shang HF; Yeh ML; Lin CP; Hwang J Clin Diagn Lab Immunol; 1996 Nov; 3(6):727-32. PubMed ID: 8914766 [TBL] [Abstract][Full Text] [Related]
3. Mice immunized with DNA encoding a modified Pseudomonas aeruginosa exotoxin A develop protective immunity against exotoxin intoxication. Shiau JW; Tang TK; Shih YL; Tai C; Sung YY; Huang JL; Yang HL Vaccine; 2000 Dec; 19(9-10):1106-12. PubMed ID: 11137245 [TBL] [Abstract][Full Text] [Related]
4. Generation of neutralizing antipeptide antibodies to the enzymatic domain of Pseudomonas aeruginosa exotoxin A. Elzaim HS; Chopra AK; Peterson JW; Goodheart R; Heggers JP Infect Immun; 1998 May; 66(5):2170-9. PubMed ID: 9573104 [TBL] [Abstract][Full Text] [Related]
5. Comparative immunochemistry of two fragments from domains Ib and III of Pseudomonas aeruginosa exotoxin A. Rutault K; Vacheron MJ; Guinand M; Michel G Infect Immun; 1993 Dec; 61(12):5417-20. PubMed ID: 8225617 [TBL] [Abstract][Full Text] [Related]
6. Analysis of immunization with DNA encoding Pseudomonas aeruginosa exotoxin A. Denis-Mize KS; Price BM; Baker NR; Galloway DR FEMS Immunol Med Microbiol; 2000 Feb; 27(2):147-54. PubMed ID: 10640610 [TBL] [Abstract][Full Text] [Related]
7. The carboxyl terminal amino acid residues of Pseudomonas aeruginosa exotoxin A involved in cell toxicity and pathogenesis, characterized by a neutralizing human monoclonal antibody. Ohtsuka H; Higuchi A; Nomura N; Horigome K; Kohzuki T; Nakamori Y; Noguchi H Biochem Biophys Res Commun; 1991 Nov; 180(3):1498-504. PubMed ID: 1719985 [TBL] [Abstract][Full Text] [Related]
8. Identification of a small epitope in domain Ib of Pseudomonas aeruginosa exotoxin A that elicits enzyme-neutralizing antibodies. Rutault K; Coin D; Vacheron MJ; Guinand M; Wallach J; Michel G FEMS Microbiol Immunol; 1992 Jul; 4(5):267-72. PubMed ID: 1381199 [TBL] [Abstract][Full Text] [Related]
9. Dual-function vaccine for Pseudomonas aeruginosa: characterization of chimeric exotoxin A-pilin protein. Hertle R; Mrsny R; Fitzgerald DJ Infect Immun; 2001 Nov; 69(11):6962-9. PubMed ID: 11598071 [TBL] [Abstract][Full Text] [Related]
10. Vaccine potential of Pseudomonas aeruginosa O-polysaccharide-toxin A conjugates. Cryz SJ; Lang AB; Sadoff JC; Germanier R; Fürer E Infect Immun; 1987 Jul; 55(7):1547-51. PubMed ID: 3110065 [TBL] [Abstract][Full Text] [Related]
11. Recombinant protein composed of Pseudomonas exotoxin A, outer membrane proteins I and F as vaccine against P. aeruginosa infection. Chen TY; Shang HF; Chen TL; Lin CP; Hui CF; Hwang J Appl Microbiol Biotechnol; 1999 Oct; 52(4):524-33. PubMed ID: 10570800 [TBL] [Abstract][Full Text] [Related]
12. Preparation of recombinant atoxic form of exotoxin A from Pseudomonas aeruginosa. Kaloshin AA; Isakov MA; Mikhailova NA; Vertiev JV Bull Exp Biol Med; 2013 Jan; 154(3):346-50. PubMed ID: 23484197 [TBL] [Abstract][Full Text] [Related]
13. Protection against exotoxin A (ETA) and Pseudomonas aeruginosa infection in mice with ETA-specific antipeptide antibodies. El-Zaim HS; Chopra AK; Peterson JW; Vasil ML; Heggers JP Infect Immun; 1998 Nov; 66(11):5551-4. PubMed ID: 9784572 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and immunologic properties in mice of vaccines composed of Staphylococcus aureus type 5 and type 8 capsular polysaccharides conjugated to Pseudomonas aeruginosa exotoxin A. Fattom A; Schneerson R; Szu SC; Vann WF; Shiloach J; Karakawa WW; Robbins JB Infect Immun; 1990 Jul; 58(7):2367-74. PubMed ID: 2114365 [TBL] [Abstract][Full Text] [Related]
15. Identification of the carboxyl-terminal amino acids important for the ADP-ribosylation activity of Pseudomonas exotoxin A. Chow JT; Chen MS; Wu HC; Hwang J J Biol Chem; 1989 Nov; 264(31):18818-23. PubMed ID: 2553721 [TBL] [Abstract][Full Text] [Related]
16. Cloning, expression and characterization of recombinant exotoxin A-flagellin fusion protein as a new vaccine candidate against Pseudomonas aeruginosa infections. Tanomand A; Farajnia S; Najar Peerayeh S; Majidi J Iran Biomed J; 2013; 17(1):1-7. PubMed ID: 23279828 [TBL] [Abstract][Full Text] [Related]
17. Recombinant chimeric vaccine composed of PRRSV antigens and truncated Pseudomonas exotoxin A (PE-K13). Yang HP; Wang TC; Wang SJ; Chen SP; Wu E; Lai SQ; Chang HW; Liao CW Res Vet Sci; 2013 Oct; 95(2):742-51. PubMed ID: 23712024 [TBL] [Abstract][Full Text] [Related]
18. Increased cytotoxic activity of Pseudomonas exotoxin and two chimeric toxins ending in KDEL. Seetharam S; Chaudhary VK; FitzGerald D; Pastan I J Biol Chem; 1991 Sep; 266(26):17376-81. PubMed ID: 1910044 [TBL] [Abstract][Full Text] [Related]
19. CD8+ T-cell mediated tumor protection by Pseudomonas exotoxin fused to ovalbumin in C57BL/6 mice. Becerra JC; Arthur JF; Landucci GR; Forthal DN; Theuer CP Surgery; 2003 Apr; 133(4):404-10. PubMed ID: 12717358 [TBL] [Abstract][Full Text] [Related]
20. Fusion protein vaccine by domains of bacterial exotoxin linked with a tumor antigen generates potent immunologic responses and antitumor effects. Liao CW; Chen CA; Lee CN; Su YN; Chang MC; Syu MH; Hsieh CY; Cheng WF Cancer Res; 2005 Oct; 65(19):9089-98. PubMed ID: 16204084 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]